Literature DB >> 36107841

Health hazards related to using masks and/or personal protective equipment among physicians working in public hospitals in Dhaka: A cross-sectional study.

Reaz Mahmud1, K M Nazmul Islam Joy2, Mohammad Aftab Rassel3, Farhana Binte Monayem4, Ponkaj Kanti Datta5, Mohammad Sharif Hossain6, Mohammad Mahfuzul Hoque5, S M Habibur Rahman Habib7, Nazmul Hoque Munna8, Mohiuddin Ahmed1, S K Jakaria Been Sayeed3, Motlabur Rahman5, Ahmed Hossain Chowdhury1, Mohammad Zaid Hossain5, Kazi Gias Uddin Ahmed1, Md Titu Miah5, Md Mujibur Rahman9.   

Abstract

BACKGROUND: Wearing masks or personal protective equipment (PPE) has become an integral part of the occupational life of physicians due to the coronavirus disease 2019 (COVID-19) pandemic. Most physicians have been developing various health hazards related to the use of different protective gears. This study aimed to determine the burden and spectrum of various health hazards associated with using masks or PPE and their associated risk factors.
METHODS: This cross-sectional survey was conducted in Dhaka Medical College from March 01-May 30, 2021, among physicians from different public hospitals in Dhaka, Bangladesh. We analyzed the responses of 506 physicians who completed case record forms through Google forms or hard copies.
FINDINGS: The mean (SD) age of the respondents was 35.4 [7.7], and 69.4% were men. Approximately 40% were using full PPE, and 55% were using N-95 masks. A total of 489 (96.6%) patients experienced at least one health hazard. The reported severe health hazards were syncope, severe dyspnea, severe chest pain, and anaphylaxis. Headache, dizziness, mood irritation, chest pain, excessive sweating, panic attack, and permanent facial disfigurement were the minor health hazards reported. Extended periods of work in the COVID-19-unit, reuse of masks, diabetes, obesity, and mental stress were risk factors for dyspnea. The risk factors for headaches were female sex, diabetes, and previous primary headaches. Furthermore, female sex and reusing masks for an extended period (> 6 h) were risk factors for facial disfigurement. The risk factors for excessive sweating were female sex and additional evening office practice for an extended period.
CONCLUSIONS: Healthcare workers experienced several occupational hazards after using masks and PPE. Therefore, an appropriate policy is required to reduce such risks.

Entities:  

Mesh:

Year:  2022        PMID: 36107841      PMCID: PMC9477277          DOI: 10.1371/journal.pone.0274169

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Introduction

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) [1], was declared a public health emergency of international concern by the Director-General of the WHO on January 30, 2020 [2]. As it was highly contagious, it rapidly became a pandemic [2,3]. Most countries experienced several waves of the infection with different SARS CoV-2 variants [4,5]. Therefore, the health systems of most countries have been exhausted due to the enormous burden of the disease. As frontliners in the control of this pandemic, healthcare workers (HCWs) have been fatigued with the substantial task of diagnosing and treating the exponentially growing number of critical patients. According to a report by Amnesty International, approximately 7000 health workers died of COVID-19 by September 3, 2020 [6]. In January 2021, the WHO reported that 1.29 million HCWs were affected, which accounted for 8% of the cases [7]. The infection rate was 10% in the initial three months and it decreased to 2.5% by September 2020 [7]. Reported death to WHO COVID-19 surveillance in health care workers due to COVID -19, from January 2020–May 2021 was only 6643. Still, a population-based estimate revealed that 115 493 health and care workers could have died from COVID-19 during that period [8]. To decrease the infection rate among HCWs, the WHO released interim guidance [9], where this global health regulating body recommended using personal protective equipment (PPE) and N-95-like masks in settings where aerosol-generating procedures are frequent and only medical masks for other instances [9]. However, wearing these protective gears has physiological and psychological impacts [10]. In the previous epidemic of SARS, protective gear-induced health hazards led to the suboptimal use of the N-95 mask [11,12]. In the recent pandemic era, protective gear-related occupational hazards have not been well addressed and quantified in the scientific literature, despite the significant suffering of physicians and other HCWs reported by some small-scale studies conducted in different parts of the world [13-15]. To date, there have been no such studies in Bangladesh. The reported hazards include headache, skin breakdown, rash, impaired cognition, sweating, dry mouth, and dyspnea [13-15]. The prevalence of hazards ranged from 66–72% in different studies [13,14]. However, studies on risk factors are limited. Prolonged use (>4 h) of masks in those with previous primary headache was related to different hazards [13,14]. Physicians in Bangladesh need to wear masks or PPE during their COVID-19 duty period and in their regular evening office practice. Most doctors need to wear these devices frequently for extended periods due to the increasing workload, as doctors are scarce in Bangladesh. We should address every aspect of their suffering in order to acknowledge their roles. This study aimed to determine the essence and spectrum of different health hazards related to the use of masks or PPE and their associated risk factors, which will make physicians as well as other HCWs aware of the health hazards. The identified risk factors will help to reduce the development of specific hazards. Furthermore, it will also increase the awareness in the concerned authorities of the burden of the problems and their attributed risks. Thus, this study will help in planning future action and preparing guidelines to reduce such occupational hazards.

Methods

This study aimed to determine the burden and spectrum of various health hazards associated with using masks or PPE and their associated risk factors among physicians. We also assessed the severities of selected ailments and their impact on daily life.

Study area and period

The study was conducted at Dhaka Medical College Hospital from March 01, 2021, to May 30, 2021. The respondents were physicians who had worked at least up to February 28, 2021, in the Dhaka Medical College Hospital, National Institute of Neurosciences and Hospital, Kurmitola General Hospital, Mugda Medical College and Hospital, and DNCC Dedicated COVID-19 Hospital. Among nine large COVID-19 dedicated hospitals in Dhaka city, we purposively selected these five hospitals (A map has been attached as Supporting information).

Study design

This was a multi-centered cross-sectional survey. We sent a Google form (by email) or a hard copy of the case record form to the physicians (to be filled out by the respondents) according to the feasibility and availability of the responding physicians.

Source population

Registered physicians (with qualifications of MBBS and higher) of all ranks who were in the duty roster of the above-mentioned hospitals, irrespective of the pattern of duty (COVID or non-COVID), whose phone number and e-mail number were available in the record of the hospital administration.

Study population

The physicians who filled up their responses either on the Google form or in the hard copy of the case record form.

Eligibility criteria

The physicians who consented to participate in the survey completely filled up the Google form or the hard copy of the case record form, and if all the information they provided was consistent, they were included in the survey. We excluded responders who provided incomplete or contradictory information. We also excluded physicians who were not using masks/respirators due to contraindications. We made the case record form in English and we used lot of medical terms. In Bangladesh we thought it would be difficult for the Nurses, pharmacist, midwiferies to understand every aspect of the case record form.

Sample size determination

Sample size was determined using the formula [16] , where z = 1.96 (at 95% confidence level), p = 50% (as the prevalence of mask-induced hazards was not known in Bangladesh), and d = allowable error/precision = 5%. The estimated sample size was 384. We were not sure how many of the approached physicians would respond. So, we approached to 1122 physicians and 506 responses were ultimately included in the study.

Sampling technique and procedure

We listed the names, e-mail addresses, and phone numbers of the physicians available in the roster of the above-mentioned hospitals and approached as many physicians as possible.

Study variables

The variables included in the Google form/hardcopy of the case record form were. Demographic variable: Age of the respondents in years and sex. Duty pattern: Physician’s position, pattern of duty (roster, morning, supervision, administrative), usual duty hours (8 hours, 12 hours, 8–12 hours), whether engaged in evening office practice. COVID-19-related questions: COVID-19 positivity, symptoms in case of COVID-19 positivity (asymptomatic, mild, moderate, severe, critical). Protection-related questions: Type of protection (full PPE, only mask), type of mask used (N-95, KN-95, surgical, homemade mask), frequency of mask wearing (daily, weekly, infrequently), whether masks are reused, duration of mask wearing (< 1 hour, 1–2 h, 3–4 h, 4–6 h, 6–8 h, >8 h), proper training on the use of PPE, condition of the doffing area (standard, average, below average). Outcome-related questions: Experience of major events (syncopal attack, severe respiratory distress, severe chest pain, anaphylaxis), frequency of serious adverse effects (once, often, every time, infrequent), minor event after wearing a mask or PPE (headache, dizziness, irritation, exertional dyspnea, chest pain, excessive sweating, panic attack, disfigurement of the face, and others), frequencies of these experiences (infrequent, often, every time). Functional impact: We assessed the functional effects of breathless and headache. Breathlessness was assessed according to the MRC score, including breathlessness on strenuous exercise or walking uphill, needing to slow down the pace of the walk, needing to stop walking after few minutes due to breathlessness, and breathlessness during routine walking. Headache impact was assessed using the HIT-6 score questionnaire comprising questions about the frequency of severe headaches, whether it limited daily activity, whether it made one wish to lie down, whether one tried to do work and got irritated, and whether it affected the ability to concentrate.

Operational definition

Physicians were defined as those who had MBBS (or higher) qualifications and were registered with the Bangladesh Medical & Dental Council (BMDC). A mask was defined as any medical mask used for the personal protection of doctors against SARS-CoV-2, which included: 1. N-95 (3M) models like 8210, 1860; 2. 3M full face/half-face respirators; 3. layered surgical masks; and, 4. homemade masks. We defined PPE as a mask along with a coverall and face shield or goggles [10]. A COVID-19-dedicated hospital or unit referred to a hospital or a unit of hospitals designated by the government for the sole treatment of COVID-19-affected patients. We described the positions of physicians, their roles in clinical practice, and their duty patterns as per job description defined by directorate general of health, Bangladesh [17]. We defined COVID-19 disease severity and presentation according to the WHO and Bangladesh guidelines on COVID-19 [18,19]. We described dyspnea as a feeling of shortness of breath either at rest or with a different grade of exertion and used an MRC score for grading it [20]. We defined headache as pain or any discomfort located in the head, excluding the face below the orbitomeatal line, including the nuchal ridge [21]. We described primary headache disorder as headache, or a headache disorder, not caused by or attributed to another disorder. It included tension-type, migraine, and cluster headaches [21]. We used the HIT-6 score questionnaire [22] to determine the functional impact of headaches. In this study, we defined syncope as a brief loss of consciousness attributed to cerebral hypoperfusion with a subsequent return to normal [23]. We described anaphylaxis as the constellation of several signs and symptoms caused by exposure to a provoking agent that occurs instantly [24]. We defined dizziness as unsteadiness other than vertigo and syncope. We defined severe adverse effects as symptoms that can endanger life or make an individual bedbound and enforce him or her to remove the mask or PPE. We described irritability as abnormal or excessive sensitivity or behavioral responses to environmental, situational, and emotional stimuli, and excessive sweating as unexpected abrupt sweating. Further, we defined a panic attack as a feeling of sudden, brief, and intense fear or apprehension without an apparent reason, and facial disfigurement as a persistent alteration in the face in the form of a change in color or scarring. Additionally, we considered severe respiratory distress, severe headache, anaphylaxis, severe chest pain, and syncope as serious adverse events. Minor adverse events included headache, dizziness, chest pain, irritation, sweating, panic attack, and facial disfigurement due to changes in the skin color. We gave the participants the option to note the adverse events they had developed in addition to these events. COVID-19 units or hospitals in Dhaka City comprised four sections: an outpatient unit called a triage section, confirmed-COVID-19 wards, suspected-COVID-19 wards, and an intensive care unit (ICU). The patient first attended the triage section of the hospital. Medical officers and residents of different postgraduate subjects scrutinized the patients. They had an 8-hour roster duty. They used PPE with N-95/KN-95 masks during their total duty period, with some exceptions. Those who received patients in the ward or ICU used the same protection for the same duration. Those who worked in the suspected-COVID-19 sections sometimes took few safety precautions. Assistant professors or junior consultants were mainly involved in clinical rounds. They needed to take full precautions for 3–4 hours, and they also had evening office practice. Associate professors, senior consultants, and professors remained on call, and they rarely needed to wear full PPE.

Data collection instrument

The data was collected either via the Google form sent via email or in the hard copy converted from the Google form (S1 File). The components of the questionnaire are described above in the variables section. We used a frequency scale for quantifying the outcomes. The questionnaire was developed by the authors as a Google form. Initial piloting for checking for internal consistency was done with 20 respondents, who were thereafter included in the research.

Data collection procedure

We made a list of physicians with their phone numbers and e-mail addresses. Initially, we approached them by email. Those who did not respond were given a second reminder and were requested to respond within 15 days. Later, we made phone calls to the non-responding physicians. We fixed appointments and approached those who gave verbal consent with a hard copy. Consenting physicians filled up the case record forms.

Data quality control

The Google form was password-protected; therefore, only the principal investigator had access to the responses made by the respondents. We conducted a reliability analysis using Cronbach alpha of 0.7. We also conducted a validity analysis of the questionnaire using Pearson correlation (S 2). In the Google form, the respondents were unable to proceed to the next section without filling the mandatory fields. In case of those who filled up the case record form, trained data collectors were present while filling up the case record form, and they ensured that the mandatory fields had been completed. Every data sheet was reviewed by two researchers; in case of any differences, it was solved with discussion. No specific management was performed for missing data. In case of conflicting answers from the respondents, we excluded the response. There was no scope of double responses in the Google form, as one could respond only once from a specified email.

Data processing and analysis

Data were analyzed using the Statistical Package for Social Sciences version 20 (IBM Corp. Armonk, NY, USA). We expressed the qualitative data as numbers and percentages, quantitative data with normal distribution as means (SD), and non-normal data as medians (IQR). We divided the respondents into groups who developed at least one hazard of any type, dyspnea of any severity, and headache of any severity. We compared them with the respondents who did not have any health hazards, dyspnea, or headache using the chi-square test. We used the unpaired t-test to test quantitative data with a normal distribution. We performed a binary logistic regression test to determine the risk factors for the development of headache, dyspnea, facial disfigurement, and excessive sweating. We described the odd ratio with 95% confidence intervals.

Ethical consideration

The Institutional Ethical Committee of Dhaka Medical College approved the study (ERC-DMC/ECC/2021/55), and all participants provided written informed consents.

Results

We contacted 1122 doctors; among them, 534 responded, giving a response rate of 47.6%. We included 506 respondents for analysis after scrutiny (Fig 1).
Fig 1

Patient selection for the cross-sectional survey.

We excluded those who did not complete the consent form and had given incomplete or contradictory responses. A total of 489 (96.6%) participants had at least one health hazard (Table 1). The mean (SD) age of the respondents was 35.4 (7.7), and 69.4% were men. A total of 327 (64%) worked in COVID-19-dedicated units of different public hospitals in Dhaka and were either medical officers or residents (50%). Two-thirds of the respondents were on the roster, and their working hours were 8 hours. Approximately 60% had additional evening office practice of a duration of 2–4 hours. Approximately 90% had to use masks daily (55%, N-95 mask) for an average duration of 4–8 hours (66%), and 40% used full PPE. The most common comorbid diseases were asthma, hypertension, diabetes, and obesity. Approximately 30% had previous primary headaches, and 17% were very stressed due to COVID-19 (Table 1).
Table 1

Demography and distribution of different risk factors among the total population and the different subgroups.

CharacteristicsTotaln-506Presence of at least 1 hazard,N = 489p-valueAny type of dyspneaN = 207p-valueHeadachen = 377p-value
Age mean (SD) 35.4(7.7)35.2(7.4)0.0135.9(7.7)0.2535.6(7.3)0.3
Age group 0.050.040.3
≤ 45 years 437(86.4)425(97.3)171(39.1)329(75.3)
>45 years 69(13.6)64(92.8)36(52.2)48(69.6)
Gender
Male,n (%)351(69.4)339(96.6)0.9148(42.2)0.38245(70.1)<0.001
Worked in COVID-19- dedicated hospital/unita, n (%)327(64.6)320(97.9)0.04,154(47.1)<0.001,260(79.5)0.001
Role in clinical practice 0.0010.0070.3
Supervision 35(6.9)30(85.7)15(42.9)23(65.7)
Clinical rounds 309(61.1)303(98.1)142(46)236(76.4)
Receiving and follow-up of the patient 162(32)256(96.3)50(30.9)118(72.8)
Duty pattern 0.040.90.07
Roster 377(74.5)367(97.3)155(41)284(75.3)
Morning 73(14.4)71(97.3)30(41.1)58(79.5)
On call 56(11.1)51(81.1)22(37.3)35(62.5)
Duty hours 0.80.0030.6
8 hours 375(74.1)362(96.5)168(44.8)278(73.9)
8–12 hours 131(25.9)127(96.9)39(28.8)100(76.3)
Evening office practicei (yes)320(63.2)311(97.2)0.38,126(39.4)0.4243(75.6)0.33,
Duration of evening practice 0.340.030.43
2 hours 115(22.7)109(94.6)45(40.2)86(74.1)
3 hours 43(8.5)42(97.6)26(56.5)29(67.4)
4 hours 107(21.1)105(98.1)32(29.9)83(77.6)
>4 hours 55(10.9)55(100)23(41.8)45(81.8)
COVID-19 status c 0.370.030.3
Positive 187(37)184(98.4)90(48.1)146(78.1)
Suspected 35(6.9)34(97.1)14(40)26(74.3)
Multiple infection 4(0.8)4(100)0(0)4(100)
Protection used 0.040.010.03
Full PPE e213(42.1)210(98.6)101(47.4)169(79.3)
Only mask 293(57.9)279(95.2)106(36.3)268(71)
Mask type 0.80.0250.27
N-95 or equivalents f 280(55.3)269(96.1)117(41.8)213(76)
KN-95 55(10.8)54(11)31(56.4)43(78.2)
Surgical mask 161(31.8)156(31.9)57(35.4)113(70.2)
Gas respirator g10(2)10(100)2(20)8(80)
Reuse of the mask (yes) 272(53.8)267(98.2)0.04,132(48.5)<0.001205(75.4)0.6
Duration of mask wearing 0.70.0010.6
<1 hour 10(2)10(100)1(10)7(70)
1–2 hours 7(1.4)7(100)2(28.6)5(71.4)
3–4 hours 20(4)19(95)16(80)15(75)
4–6 hours 152(30)148(97.4)53(34.9)116(76.3)
6–8 hours 183(36.2)174(95.1)79(43.2)142(77.6)
>8 hour 134(26.5)131(97.8)56(41.8)92(68.7)
Training on infection control measures, and donning and doffing (yes) 258(51.1)255(98.8)0.005121(46.9)0.005,201(77.9)0.07
Comorbidity
Asthma 72(14)72(100)0.06,42(57.5)0.00161(85.9)0.02,
Diabetes 40(7.9)40(100)0.2,23(57.5)0.02,35(87.5)0.04,
Hypertension 65(12.8)64(98.5)0.7,24(36.9)0.554(83.1)0.08
Obesity 60(11.5)56(93.3)0.13,37(61.7)<00138(63.3)0.03
Previous primary headache h 156(30.8)152(97.4)0.565(41.7)0.8141(90.4)0.001
Mental stress j 0.230.0010.04
Highly stressed 90(17.8)84(93.3)38(42.2)75(83.3)
Worried but could cope up 280(55.3)273(97.5)131(46.6)207(73.9)
Slightly worried 119(23.5)115(96.6)35(29.4)86(72.3)
Not worried 17(3.4)17(100)3(17.6)9(52.9)

a-A COVID-19-dedicated hospital or unit refers to hospital or a unit of a hospital designated by the government for the sole treatment of COVID-19-affected patients.

b-Role in clinical practice and duty pattern were described as per job description defined by directorate general of health, Bangladesh.

c-As described by the case definition of WHO.

d-As described by WHO and Bangladesh guidelines.

e-a mask along with other protective equipment for protection of the other parts of the body, which includes a coverall and/or face shield or goggles.

f-N-95 (3M) models like 8210, 1860.

g-3M full-face/half-face respirators.

h-Primary headache disorder was defined as headache, or a headache disorder, not caused by or attributed to another disorder, such as tension-type headache, migraine, and cluster headaches.

i-Evening clinical practice in own office after the regular duty in the public hospital.

j-Stress is the inability to cope with mental pressure and being overwhelmed with anxiety.

COVID-19: Corona virus disease 19.

PPE: Personal Protective Equipment.

a-A COVID-19-dedicated hospital or unit refers to hospital or a unit of a hospital designated by the government for the sole treatment of COVID-19-affected patients. b-Role in clinical practice and duty pattern were described as per job description defined by directorate general of health, Bangladesh. c-As described by the case definition of WHO. d-As described by WHO and Bangladesh guidelines. e-a mask along with other protective equipment for protection of the other parts of the body, which includes a coverall and/or face shield or goggles. f-N-95 (3M) models like 8210, 1860. g-3M full-face/half-face respirators. h-Primary headache disorder was defined as headache, or a headache disorder, not caused by or attributed to another disorder, such as tension-type headache, migraine, and cluster headaches. i-Evening clinical practice in own office after the regular duty in the public hospital. j-Stress is the inability to cope with mental pressure and being overwhelmed with anxiety. COVID-19: Corona virus disease 19. PPE: Personal Protective Equipment. Those who had experienced at least one health hazard were relatively younger (mean [SD] age-35.2 [7.2] years; p = 0.001). Those who worked in COVID-19-dedicated hospitals/units (p-value 0.04) and reusing mask (p-value 0.04) were more likely to have experience at least one hazard. Furthermore, those who used only masks developed less hazards than those who used full PPE p-value 0.04) (Table 1). Participants who had experienced respiratory distress of any severity were less than 45 years old (171 [39.1%]) (P-value-0.04). Moreover, working in the COVID-19-dedicated unit, reusing masks, and having bronchial asthma, diabetes, and obesity increased the risk of respiratory distress. Those whose duty hours were <8 hours were (p-value 0.003) less likely to have respiratory distress than those whose duty hours were >8 hours (Table 1). More women experienced headaches ((p value <0.001). The use of full PPE, bronchial asthma, diabetes, and previous primary headache increased the risk of headache (Table 1). Overall, 23 (5%) patients developed syncope; 96 (19%), severe respiratory distress; 32 (6%), severe chest pain; and, 6 (1%), anaphylaxis. Syncope (48%) and anaphylaxis (50%) occurred once in participants (48%). Severe respiratory distress (44%) and chest pain (72%) occurred infrequently (44%) (Fig 2a).
Fig 2

The spectrum of overall health hazards associated with using masks or PPE.

a. spectrum of severe health hazards related to using masks and or PPE b. spectrum of minor hazards related to using of masks and or PPE.

The spectrum of overall health hazards associated with using masks or PPE.

a. spectrum of severe health hazards related to using masks and or PPE b. spectrum of minor hazards related to using of masks and or PPE. Overall, 377 (75%) patients developed headache; 143 (28%), dizziness; 232 (46%), irritation; 12 (2%), chest pain; 153 (30%), excessive sweating; and, 4%, panic attacks [Fig 2b]. In addition, 133 (26.3%) patients developed permanent facial disfigurement. Headache, excessive sweating (51%), and dizziness (36%) frequently occurred. In contrast, irritation (40%) and exertional dyspnea (46%) occurred infrequently (Fig 2b). Most respondents reported respiratory distress on walking uphill (122 [52%]). Most respondents (148 [39%]) experienced severe headaches for some time. Approximately 86 (23%) respondents experienced severe headaches very often or always. The health hazards reported by participants included tiredness (104 [20.5%]), loss of concentration (142 [28%]), desire to lie down frequently (87 [17.2%]), and limitation in daily activity (142 [28.1%]) (Table 2).
Table 2

Severity (dyspnea and headache) and the functional impact of health hazards on the daily life of the physicians.

TraitNumberPercentage
Severity grade of dyspnea a
Strenuous exercise2724
Walking uphill12252
Slowing down the pace2812
Stopping to walk115
Breathless on routine exercise156
Experienced severe headache b
Never5815
Rarely8523
Sometimes14839
Very often4512
Always4111
Loss of concentration in the last 4 weeks
Never26151.6
Rarely6613
Sometimes14228
Very often336.5
Always40.8
Irritation in the last 4 weeks
Never32263.6
Rarely6412.6
Sometimes8817.4
Very often295.7
Always30.6
Tiredness in the last four weeks
Never30460
Rarely6713.2
Sometimes10420.5
Very often295.7
Always20.4
Desire to lie down frequently
Never31562.2
Rarely5510.9
Sometimes8717.2
Very often346.7
Always153
Limitation in daily activities
Never17634.8
Rarely9218.2
Sometimes14228.1
Very often5611.1
Always407.9

a. According to the MRC scale.

b. According to the verbal rating scale.

a. According to the MRC scale. b. According to the verbal rating scale. Risk factors were analyzed using binary logistic regression. Initially, univariate logistic regression was performed (S2 Table), after which multivariate analysis with the forward conditional method was used. Working in COVID-19-dedicated units (OR, 95% CI, p = 1.3, [1.3–3], 0.002), extended working hours (OR, 95% CI, p-value 0.7, [0.5–0.9], 0.001), reusing masks (OR, 95% CI, p-value 1.7, [1.7–2.5], 0.007), presence of diabetes (OR, 95% CI, p-value 2.1, [1–4.2], 0.04), and obesity (OR, 95% CI, p-value 2.9, [1.6–5.2], 0.001). increased the chance of dyspnea of any severity. Th The physicians with low personal stress levels developed less dyspnoea (OR, 95% CI, p-value 0.7, [0.5–0.9], 0.01) (Table 3).
Table 3

Risk factors of respiratory distress, headache, facial disfigurement, and excessive sweating.

Trait Reference B SE wald P-value OR 95%CI
Respiratory distress b
Working in COVID-19-dedicated unitsYes0.670.2110.70.0021.91.3–3
Duty hours<8 hour-0.350.146.70.010.70.5–0.9
Reuse of maskYes0.530.207.30.0071.71.2–2.5
AsthmaYes0.740.287.010.0082.11.2–3.6
DiabetesYes0.730.364.20.042.11.0–4.2
ObesityYes1.010.312.60.0012.91.6–5.2
Personal stress levelLow-0.350.136.50.010.70.5–0.9
Constant headachec-0.160.410.170.680.84
SexMale-0.910.2612.040.0010.40.24–0.67
Working in COVID-19-dedicated unitsYes0.690.229.80.0022.011.3–3.1
DiabetesYes1.080.514.50.032.91.1–8.1
Stress levelLow-0.350.155.70.010.70.52–0.9
Previous primary headacheYes1.50.326.5<0.0014.72.6–8.5
Constant1.60.415.4<0.0015.3
Facial disfigurement d
SexMale-0.910.2612.040.0010.40.24–0.67
Evening practiceNo-0.590.217.60.0060.550.35–0.84
Protection usedMask only-0.60.217.70.0050.550.34–0.84
Frequency of mask useDaily0.560.245.70.021.81.1–2.8
Reuse of maskYes0.580.26.90.021.81.2–2.8
Duration of mask wearing>6 hours0.270.116.010.0141.31.1–1.6
Constant-2.60.811.20.0010.07
Excessive sweatinge
Age-0.030.024.10.040.90.9–0.99
SexMale-0.80.211.70.0010.40.28–0.7
Duty hours<8 hour-0.60.29.40.0020.50.4–0.8
Evening office practiceNo-1.50.414.80.0010.210.09–0.5
Practice duration>4 hours0.40.149.90.0021.51.2–2.1
COVID-19 positivityPositive0.60.1613.10.0011.81.3–2.5
Protection usedMask only-1.70.2641.80.0010.180.11–0.3
Mask TypeNon-Filtering0.300.144.80.031.31.1–1.8
HypertensionYes0.890.337.40.0072.41.2–4.6
constant3.50.820.10.00134.9

a. Analyzed with multivariate binary logistic regression; forward conditional methods were used.

b. Omnibus test of model coefficients, 0.000; Nagelkerke R, 19.9; Hosmer and Lemeshow test, 0.48; sensitivity, 67.8; conditional forward method; model at step 7.

c. Omnibus test of model coefficients, 0.000; Nagelkerke R, 18.8; Hosmer and Lemeshow test, 0.63; sensitivity, 75.2%; conditional forward method; model at step 5.

d. Omnibus test of model coefficients, 0.000, Nagelkerke R, 13.8; Hosmer and Lemeshow test, 0.82; sensitivity, 75.1%; conditional forward method; model at step 5.

e. Omnibus test of model coefficients, 0.000; Nagelkerke R, 32.1; Hosmer and Lemeshow test, 0.16; sensitivity, 78.1%; conditional forward method; model at step 9.

COVID-19: Corona virus disease 19.

OR: Odd ratio.

SE: Standard error.

a. Analyzed with multivariate binary logistic regression; forward conditional methods were used. b. Omnibus test of model coefficients, 0.000; Nagelkerke R, 19.9; Hosmer and Lemeshow test, 0.48; sensitivity, 67.8; conditional forward method; model at step 7. c. Omnibus test of model coefficients, 0.000; Nagelkerke R, 18.8; Hosmer and Lemeshow test, 0.63; sensitivity, 75.2%; conditional forward method; model at step 5. d. Omnibus test of model coefficients, 0.000, Nagelkerke R, 13.8; Hosmer and Lemeshow test, 0.82; sensitivity, 75.1%; conditional forward method; model at step 5. e. Omnibus test of model coefficients, 0.000; Nagelkerke R, 32.1; Hosmer and Lemeshow test, 0.16; sensitivity, 78.1%; conditional forward method; model at step 9. COVID-19: Corona virus disease 19. OR: Odd ratio. SE: Standard error. For headache, female sex (for male sex OR, 95% CI, p-value 0.4, [0.24–0.67], 0.001), working in a COVID-19-dedicated unit (OR, 95% CI, p = 2.01, [1.3–3.1], 0.002), presence of diabetes (OR, 95% CI, p-value 2.9, [1.1–8.1], 0.03), and previous primary headache (OR, 95% CI, p-value 4.7, [2.6–8.5], <0.001), increased the susceptibility to headache of any severity (Table 3). Female sex (for male sex OR, 95% CI, p-value 0.4, [0.24–0.67], 0.001), having evening practice (for no practice OR, 95% CI, p-value 0.55, [0.35–0.84], 0.006), using protection of high level (for low-level protection OR, 95% CI, p-value 0.55, [0.34–0.86], 0.005), increasing frequency of mask use (OR, 95% CI, p-value 1.8, [1.2–2.8], <0.001), increasing duration of mask wearing (OR, 95% CI, p = 1.3, [1.1–1.6], 0.001), increased the prevalence of facial disfigurement of any type (Table 3). Lower age group (for higher age OR, 95% CI, p-value 0.9, [0.9–0.99], 0.04), female sex (for male, OR, 95% CI, p-value 0.4, [0.28–0.7], 0.001), evening practice (for no practice OR, 95% CI, p-value 0.21, [0.09–0.5], 0.004), longer practice duration (OR, 95% CI, p-value 1.5, [1.2–2.1], 0.001), COVID-19 positivity (OR, 95% CI, p-value 1.8, [1.3–2.5], 0.001), using high-level protection (for low-level protection OR, 95% CI, p-value 0.18, [0.11–0.3], 0.001), mask type (OR, 95% CI, p-value 1.3, [1.1–1.8], 0.03), and hypertension (OR, 95% CI, p-value 2.4, [1.2–4.6], 0.007) were associated with the increased prevalence of excessive sweating (Table 3).

Discussion

This study demonstrated the occupational hazards related to the use of masks or PPE among physicians. Few participants developed severe respiratory distress, syncope, severe chest pain, and anaphylaxis, which is concerning. A significant number of participants developed headaches, dizziness, exertional dyspnea, mood irritation, excessive sweating, panic attacks, chest pain, and facial disfigurement. These “occupational hazards” have caused significant functional problems for a large number of physicians. The risk factors for the different health hazards were age group, female sex, diabetes, hypertension, mental stress, reuse of masks, wearing masks for a longer duration, using PPE, using KN-95 masks, and COVID-19 positivity. This study was a novel approach to assess various health problems experienced by physicians due to the use of protective gear during the pandemic, in addition to being affected by the deadly virus. It would acknowledge their sacrifice during the pandemic. Although the WHO recommends the use of filtering masks in aerosol-generating areas [10], many physicians are using filtering masks in general OPD patient consultations and indoor environments with the risk of COVID-19 because of the lack of capacity to conduct RT-PCR tests in all patients, as well as the negligence of people in using masks. Therefore, users of filtering masks outnumbered the physicians working in COVID-19-dedicated units (65% vs. 70%). The number of physicians with at least some degree of stress in this study was high (approximately 70%), consistent with the results of previous studies on the psychological assessment of doctors (50%) [25]. Despite using filtering masks, a number of physicians had either confirmed or suspected COVID-19 infections (~44%) and moderate-to-severe disease. The prevalence was higher than that reported in other studies (5–21%) [26-29]. The increased prevalence in this study might be due to the lack of training, reuse of masks, and extended duty hours. Furthermore, a quarter of the physicians needed to wear masks for more than eight hours due to the shortage of doctors in many hospitals, although the WHO recommends using masks or PPE for 6 hours and reusing them only after reprocessing [10]. The physicians in this study experienced several health hazards similar to those in other studies [30,31]. Among the health hazards, dyspnea is the most concerning, which might be due to increasing resistance during inhalation, the addition of 50–100 ml dead space (the mask area), and re-breathing of a small volume of exhaled gas within that space [32]. Furthermore, wearing the mask can increase end-tidal CO2 levels [12,33,34]. Filtering masks usually offer more resistance than surgical masks [32], and doctors using filtering masks reported more respiratory distress than others in this study. Some studies conducted in the pre-COVID-19 era found that filtering masks did not impose any respiratory distress when worn for 1 h [35]. However, in the COVID era, physicians need to wear filtering masks for extended periods. Patients with obstructive pulmonary disease with modified Medical Research Council dyspnea scale scores >3 or FEV1 < 30% predicted should be cautious while wearing masks or PPE [36]. Filtering masks increase airway resistance to 126% and 122% during inspiration and expiration, respectively, and reduce the gas exchange volume by 37% in each breath [37]. Reuse of the filtering mask can cause pore clogging. Thus, it increases breathing resistance [10]. Furthermore, moisture increases airway resistance by 3% [38]. Therefore, the duration of wearing filtering masks should be limited to 6 h. One should not reuse masks, and patients with obstructive pulmonary disease should be cautious. According to this study, individuals with obesity and uncontrolled diabetes should be carefully monitored. Headache was the second most common health hazard reported in this study (74%). Its prevalence was similar to that reported in other studies [13 (71.4%, New York), 28 (81%, Singapore)]. Little difference in the prevalence of headache was found among the different geographic locations, such as the USA (71%) [14], Singapore [81%], and Morocco (62%) [39]. Headache might be due to compression, hypercapnia, or stress. Headaches arise from the sustained pressure on pericranial soft tissues resulting from donning objects with tight bands or straps around the head (e.g., hat, helmet, goggles worn during swimming or diving, or frontal lux devices) and have been previously reported in the literature [30,40-45]. Furthermore, alterations in cerebral hemodynamics due to build-up of CO2 after wearing filtering masks may also cause headaches [46]. A study in the USA reported that 25% of the respondents experienced a headache after 3 h of wearing a mask [13]. High mental stress (70%) and previous primary headache (30%) may have increased the risk of headaches in this study. Therefore, physicians must address the underlying primary headache. Anaphylaxis is one of the rarest, but most serious, health hazards reported in this study. This is probably due to hypersensitivity to the components and chemicals used in masks or PPE. Several studies have reported contact dermatitis related to the use of protective gears [14,47-49]. However, these 1% cases were probably the first to be reported. Syncope (5%) and dizziness (28%) reported in this study may be due to prolonged standing and N-95-induced respiratory alkalosis [50]. Hypocarbia may cause cerebral vasoconstriction. Low intracranial pressure and cardiac arrhythmia [50] may be involved in the underlying pathophysiology of syncope and dizziness. Permanent facial disfigurement (26%) is an exigent cosmetic problem reported in this study; one study in the USA found skin problems in 51% of the respondents. This may be due to contact dermatitis, scaling, acne, skin breakdown, and other skin conditions that can occur with frequent mask usage [14] or reuse of unhygienic masks. Furthermore, wearing masks for long durations also changes the local natural skin milieu and leads to local rises in temperature and humidity. It may cause an increase in skin pH, redness of the skin, fluid loss, and increased sebum production [51]. In this study, we found that health hazards caused a significant number of physicians to become irritated and limit their daily activities. A recent review article also described the neurological and psychiatric impacts of filtering masks [51]. This study included an adequate number of participants; the nature of work of the study population was relatively homogenous. All participants were experts and knowledgeable in their respective fields. Therefore, it was easier for them to understand the technical language used in the questionnaires. The responses are expected to be valid, representative, and reliable. The validity test also reflected this scenario. In this study, the participants themselves provided the responses. Therefore, there may have been inappropriate responses due to a lack of understanding and communication. The reported experiences were real-time due to the nature of the study; however, the results might change with time. Therefore, a prospective study is warranted. Again, in this study respond modalities are not similar to all respondents. We conducted the study mainly among physicians of different government institutes in Bangladesh, a tropical country with a hot and humid environment, where most physicians need to work without air-conditioning systems, proper resting facilities, or adequate rehydration opportunities. Working patterns and workloads might differ in various circumstances and geographical locations. We conducted the study on the physicians only; duty patterns, awareness, and training might differ among the other healthcare workers. Therefore, these results cannot be generalized for all instances. A multicenter, multinational study, inclusive of all sectors of the health care providers, is required to generalize these finding.

Conclusions

Healthcare workers in the pandemic era are experiencing several occupational hazards, especially headache, different degrees of dyspnea, facial disfigurement, and chest pain, which also cause some functional disabilities. The important risk factors identified for different hazards were female sex and the presence of comorbidities, such as hypertension and diabetes. Wearing masks for longer durations and reusing them were also risk factors for some hazards.

A map showing the location of the hospitals.

(JPG) Click here for additional data file.

Validity test.

(XLS) Click here for additional data file.

Univariate logistic regression analysis of the risk factors of respiratory distress, headache, facial disfigurement, and excessive sweating.

(DOCX) Click here for additional data file.

Google form.

(PDF) Click here for additional data file.

Editage edited manuscript.

(DOCX) Click here for additional data file.

Editage certificate.

(PDF) Click here for additional data file.

Data set.

(XLSX) Click here for additional data file. 17 Mar 2022
PONE-D-21-25497
Health hazards related to using masks and, or personal protective equipment among the physicians working in different public hospitals in Dhaka: A cross-sectional study
PLOS ONE Dear Dr. Reaz Mahmud , Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR Comments: Why you used the heading “Methods and Materials”? Is there a material that used for this study? if not, please omit the “materials”. The methods will be better if structered in this way; Study Area and Period, Study Design, source population, study population, Eligibility criteria, Sample Size Determination, Sampling Technique and Procedures, Study Variables, Operational Definitions, Data Collection Instrument, Data Collection Procedures, Data Quality Control, and Data Processing and Analysis. Specially, this section should be critically addressed! The authors should clearly explain their Eligibility criteria as; inclusion and exclusion criteria. The authors must operationalize their outcome variables. How did they measure their outcome variables? Concerning to the sample size calculation for this study, the authors explained as …. So the estimated sample size was 384. We included a total of 506 respondents in this study” why you didn’t used the calculated sample size? This needs a justification. How did they get the study subjects? They have to clearly address their sampling technique? Since you conducted the data collection with online means, how did you keep the data quality for this study? Study instrument: have you developed, adapted or adopted the questionnaires? You have to clearly explain about the questionnaires you used because this is crucial. You have to report the reliability analysis finding for your questionnaires. Add the response rate. Discussion: discuss by using the scientific reasoning. Conclusion: avoid numbering. Make it a paragraph. Focus on your main findings, clinical implications, recommendations etc. Please include the following items when submitting your revised manuscript: A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.​ Please include the following items when submitting your revised manuscript: If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. Please submit your revised manuscript by April 20, 2022. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to  https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. We look forward to receiving your revised manuscript. Kind regards, Addisu Dabi Wake Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf. 2. Thank you for stating the following in the Funding Section of your manuscript: “Directorate General of Health services, Government of the People’s Republic of Bangladesh” We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “The research project received a grant of 2000 $ from Directorate General of Health Services, Government of People's Republic of Bangladesh. None of the author received any honorarium. he funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Manuscript Title: Health hazards related to using masks and, or personal protective equipment among the physicians working in different public hospitals in Dhaka: A cross-sectional survey 1. Title: it is researchable, interesting and targeted. The manuscript had presented Health hazards related to using masks and, or personal protective equipment among the physicians working in public hospitals. It can be a valuable scientific literature if published after incorporation of the comments raised. 2. Abstract: - 3. Introduction - 4. Methods �  Better to state about the brief background of your study area, from how many hospitals the physicians recruited. �  Why you conduct only on physicians, what about other health care workers like Nurses, pharmacists, midwiferies, Anesthesia…? �  If you conceptual framework it is better to show the relationship of predictor and outcome variables in the form of conceptual framework. �  Better to clarify about your sample size determination, I think you used census method, so what is the advantage of using single population proportion formula? �  What types of technique you used to keep/control your data quality? Since data quality is the corner stone for mixed research approach. �  I haven’t seen about your tool/questionnaire or checklist you used to collect your data; therefore, please try to state about the checklist you used and where you adopt or adapt the checklist or questionnaire. . 5. Result �  No need to state repeat similar concepts in different data presentation form. Therefore, it is better to state either in table or graph with brief description, or in text form…. �  Your logistic regression model is not clear? o You only conducted bivariable logistic regression which is not enough and didn’t consider the confounders, and your odds ratio is not clear whether it is AOR or COR. �  If your odds ratio (OR) is Adjusted Odds Ratio (AOR), where is your COR and what was the criteria to pass your variables from bivariable to multi variable logistic regression? �  If your odds ratio (OR) is COR you need to conduct multivariable regression model for better decision since COR is didn’t consider other confounding variables. �  If you refine the above things, your study would be valuable. Therefore, try to focus on your logistic regression model. Reviewer #2: Reviewer comments Manuscript Number: PONE-D-21-25497 Title "Health hazards related to using masks and, or personal protective equipment among the physicians working in different public hospitals in Dhaka: A cross-sectional study". Generally speaking: Thank you for providing me the opportunity to review this manuscript that raises important issues about health hazards related to using masks and/or personal protective equipment in one of the developing countries. Comment 1: 1. ABSTRACT: a) Results: • The number of samples should be mentioned in the methodology of the abstract. • (35.4[7.7]) these numbers should be clarified. • Furthermore, the feminine female gender and reusing masks for an extended period were the risk factors for facial disfigurement. Comment 2: 2. INTRODUCTION: a) The text of the introduction does not seem to have coherence and integrity. It should be concise and targeted to the aim. b) Global/ Regional/ Bangladesh prevalence of health hazards related to using of personal protective equipment among health workers should be mentioned. The current situation of other developing and developed countries should also be added. c) Risk factors associated with health hazards related to using of personal protective equipment should be clearly stated. d) Explaining why this topic was chosen for analysis in this article is not well written. The benefits of conducting the study to the community should be explained. Comment 3: 3. METHODS: Generally, the information mentioned under the methods are too long with redundancy and diffusion and should be divided into several sub-sections as follow: a) Type of the study b) Study setting c) Study Participants: The characteristics of the study participants should be mentioned as inclusion criteria and exclusion criteria (if any) d) Sample size e) Study tools: • There was no clear mention of the questionnaire used. Was it newly developed by the authors (if so, include the reference)? Was it piloted to assess its internal consistencies? Was it validated? • It is advisable to include the questions as per each domain in the methodology, how to score the questionnaire, specify the cut points in the questionnaire, as well as how long did it take to complete each questionnaire? f) Data management analysis g) Ethical considerations Comment 4: 4. RESULTS: 1) In line 237, I don't agree with the term ''mostly'' when describing those worked in COVID-19 dedicated units, they were about two thirds and not the most of study population. Again, in line 238, the term ''most'' for describing the respondents worked on the roster is not true, they were three quarters and not the most of study population. In line 280, the term ''most'' was repeated twice while the percentages were 52% and 39%. It is advisable to revise the rest of the result comments. 2) How does increasing personal stress level increased the chance of dyspnea with any severity, while OR is 0.7. 3) In line 284, it is table 2 not table 3. 4) Assessment of Relative Risk in table 1 should be explained. Comment 5: 5. DISCUSSION: a) Should give reasons for the risk factors. The manuscript could be greatly strengthened if the authors could provide highlight on the risk factors in other developing and developed countries with similar context. b) Compare the findings of the study with other findings and state the reasons for the strengths and weaknesses in each section. a) Line 356: “Headache prevalence is similar to other studies”. It is advisable to give the prevalence of headache and other health hazards which was not mentioned, as well as the prevalence of the risk factors. b) Line 364: regular psychological assessment and counseling for managing the stress c) The sentence “It was a cross-sectional study” was repeated many times. e.g, it was repeated two times in the last paragraph of the discussion. Comment 6: 6. CONCLUSION: It is unclear. It should be specific and based on the findings of the study. Comment 7: 7. STRENGTHS AND LIMITATIONS: a) Please analyze the strengths of the study. b) Last paragraph of discussion is the limitations of the study Comment 8: 8. REFERENCES: a) Please revise the Harvard Vancouver method. b) All references should be written in the same way. Comment 9: English needs to be revised. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. Submitted filename: comments.docx Click here for additional data file. Submitted filename: Reviewer comments PONE-D-21-25497.docx Click here for additional data file. 23 Apr 2022 Response to Academic editor 1. Why you used the heading “Methods and Materials”? Is there a material that used for this study? if not, please omit the “materials”. Response: Thank you for the note. There is no material used in this study. It was a mistake. I have omitted materials. (line 150) 2. The methods will be better if structured in this way; Study Area and Period, Study Design, source population, study population, Eligibility criteria, Sample Size Determination, Sampling Technique and Procedures, Study Variables, Operational Definitions, Data Collection Instrument, Data Collection Procedures, Data Quality Control, and Data Processing and Analysis. Specially, this section should be critically addressed! Response: Thanks for the advice. I have revised the methods as per your instructions. (Line-154,160,169,172, 178, 182, 212,253,259, 265,277, 288) 3. The authors should clearly explain their Eligibility criteria as; inclusion and exclusion criteria. Response: mentioned in the specific section (line 172-177) 4. The authors must operationalize their outcome variables. How did they measure their outcome variables? Response: the definition of the outcome variables was added in the operational definition section and Measurement of dyspnea was made with MRC score and headache with HIT-6 score questionnaire. (Line: 199-211) 5. Concerning to the sample size calculation for this study, the authors explained as …. So the estimated sample size was 384. We included a total of 506 respondents in this study” why you didn’t used the calculated sample size? This needs a justification. Response: We were not sure how many of the approached physicians would respond. So, we approached to 1122 physicians and 506 responses were ultimately included in the study. As this line is creating confusion, we deleted this line. 6. How did they get the study subjects? They have to clearly address their sampling technique? Response: added in the corresponding section (line 182-185) 7. Since you conducted the data collection with online means, how did you keep the data quality for this study? Response: added in the corresponding section (line-265-276) 8. Study instrument: have you developed, adapted or adopted the questionnaires? You have to clearly explain about the questionnaires you used because this is crucial. You have to report the reliability analysis finding for your questionnaires. Response: we developed the questionnaire. We made the reliability with Cronbach’s alpha, which was 0.7. and validity test with Pearson correlation. Added in the text. (line-267-279) 9. Add the response rate. Response: We accessed a total of 1122 doctors; among them, 534 doctors responded. Response rate (47.6%). Added in the text (line 292-293) 10. Discussion: discuss by using the scientific reasoning. Response: some revision made as per your instruction 11. Conclusion: avoid numbering. Make it a paragraph. Focus on your main findings, clinical implications, recommendations etc. Response: Corrected in the text as per your instruction Response to the reviewer: Thank you for reviewing the article. I have tried to address all the points raised in your review comments. Reviewer #1: Manuscript Title: Health hazards related to using masks and, or personal protective equipment among the physicians working in different public hospitals in Dhaka: A cross-sectional survey 1. Title: it is researchable, interesting and targeted. The manuscript had presented Health hazards related to using masks and, or personal protective equipment among the physicians working in public hospitals. It can be a valuable scientific literature if published after incorporation of the comments raised. 2. Abstract: - 3. Introduction - 4. Methods �  Better to state about the brief background of your study area, from how many hospitals the physicians recruited. Response: Stated (line-157-159) �  Why you conduct only on physicians, what about other health care workers like Nurses, pharmacists, midwiferies, Anesthesia…? Response: We made the case record form in English and we used lot of medical terms. In Bangladesh we thought it would be difficult for the Nurses, pharmacist, midwiferies to understand every aspect of the case record form. �  If you conceptual framework it is better to show the relationship of predictor and outcome variables in the form of conceptual framework. Response: this study is not a conceptual frame work �  Better to clarify about your sample size determination, I think you used census method, so what is the advantage of using single population proportion formula? Response: we included only the physicians. So, we used single population proportion formula �  What types of technique you used to keep/control your data quality? Since data quality is the corner stone for mixed research approach. Response: Thanks for your concern. I have revised the writing and explained it in line-265-276. �  I haven’t seen about your tool/questionnaire or checklist you used to collect your data; therefore, please try to state about the checklist you used and where you adopt or adapt the checklist or questionnaire. . Response: added in the supplement-1 5. Result �  No need to state repeat similar concepts in different data presentation form. Therefore, it is better to state either in table or graph with brief description, or in text form…. Response: Thank you for your advice. I have corrected as much as possible. �  Your logistic regression model is not clear? o You only conducted bivariable logistic regression which is not enough and didn’t consider the confounders, and your odds ratio is not clear whether it is AOR or COR. �  If your odds ratio (OR) is Adjusted Odds Ratio (AOR), where is your COR and what was the criteria to pass your variables from bivariable to multi variable logistic regression? �  If your odds ratio (OR) is COR you need to conduct multivariable regression model for better decision since COR is didn’t consider other confounding variables. Response: It was adjusted odd ratio. We used forward conditional methods in the regression model. Crude odd ration was added in the supplement 3. (line 342-344) �  If you refine the above things, your study would be valuable. Therefore, try to focus on your logistic regression model. Reviewer #2: Reviewer comments Manuscript Number: PONE-D-21-25497 Title "Health hazards related to using masks and, or personal protective equipment among the physicians working in different public hospitals in Dhaka: A cross-sectional study". Generally speaking: Thank you for providing me the opportunity to review this manuscript that raises important issues about health hazards related to using masks and/or personal protective equipment in one of the developing countries. Comment 1: 1. ABSTRACT: a) Results: • The number of samples should be mentioned in the methodology of the abstract. Response: Added (line-80) • (35.4[7.7]) these numbers should be clarified. Response: It was mean (SD) age, corrected (Line-83) • Furthermore, the feminine female gender and reusing masks for an extended period were the risk factors for facial disfigurement. Response: Rewritten as “Furthermore, the female gender, reusing masks for an extended period (> 6 hours) were the risk factors for facial disfigurement.” Comment 2: 2. INTRODUCTION: a) The text of the introduction does not seem to have coherence and integrity. It should be concise and targeted to the aim. b) Global/ Regional/ Bangladesh prevalence of health hazards related to using of personal protective equipment among health workers should be mentioned. The current situation of other developing and developed countries should also be added. Response: Thank you for your advice. I have rewritten this section, tried to be concise and targeted as per your advice. But we found very few comprehensive studies in this regard. So current situation in the developed and developing countries cannot be added. I believe it would be better if we could add it. c) Risk factors associated with health hazards related to using of personal protective equipment should be clearly stated. Response: Added in the introduction to some extent, according to other studies. (line-137-139) d) Explaining why this topic was chosen for analysis in this article is not well written. The benefits of conducting the study to the community should be explained. Response: Rewritten. Line-146-149 Comment 3: 3. METHODS: Generally, the information mentioned under the methods are too long with redundancy and diffusion and should be divided into several sub-sections as follow: a) Type of the study b) Study setting c) Study Participants: The characteristics of the study participants should be mentioned as inclusion criteria and exclusion criteria (if any) d) Sample size e) Study tools: • There was no clear mention of the questionnaire used. Was it newly developed by the authors (if so, include the reference)? Was it piloted to assess its internal consistencies? Was it validated? • It is advisable to include the questions as per each domain in the methodology, how to score the questionnaire, specify the cut points in the questionnaire, as well as how long did it take to complete each questionnaire? f) Data management analysis g) Ethical considerations Response: rewritten as per instruction (line-154,160,169,172, 178, 182, 212,253,259, 265,277, 288) Comment 4: 4. RESULTS: 1) In line 237, I don't agree with the term ''mostly'' when describing those worked in COVID-19 dedicated units, they were about two thirds and not the most of study population. Again, in line 238, the term ''most'' for describing the respondents worked on the roster is not true, they were three quarters and not the most of study population. In line 280, the term ''most'' was repeated twice while the percentages were 52% and 39%. It is advisable to revise the rest of the result comments. Response: Thank you for your advice I have corrected these. (line- 299, 300, 301 etc) 2) How does increasing personal stress level increased the chance of dyspnea with any severity, while OR is 0.7. Response: corrected (Line-348-349) 3) In line 284, it is table 2 not table 3. Response: Corrected 4) Assessment of Relative Risk in table 1 should be explained. Response: I have rewritten it and explained in 309-323 Comment 5: 5. DISCUSSION: a) Should give reasons for the risk factors. The manuscript could be greatly strengthened if the authors could provide highlight on the risk factors in other developing and developed countries with similar context. Response: Thank you for your advice. I have rewrite tis section, tried to focused on your concern Limited literature was found even after extensive search to compare. b) Compare the findings of the study with other findings and state the reasons for the strengths and weaknesses in each section. Response: Tried to address as far as possible. We found a few study to compare. a) Line 356: “Headache prevalence is similar to other studies”. It is advisable to give the prevalence of headache and other health hazards which was not mentioned, as well as the prevalence of the risk factors. Response: Corrected (line 419, 440, b) Line 364: regular psychological assessment and counseling for managing the stress Response: Corrected c) The sentence “It was a cross-sectional study” was repeated many times. e.g, it was repeated two times in the last paragraph of the discussion. Response: Corrected Comment 6: 6. CONCLUSION: It is unclear. It should be specific and based on the findings of the study. Response: The writing of the conclusion was revised. Comment 7: 7. STRENGTHS AND LIMITATIONS: a) Please analyze the strengths of the study. b) Last paragraph of discussion is the limitations of the study Response: Added in the text Comment 8: 8. REFERENCES: a) Please revise the Harvard Vancouver method. b) All references should be written in the same way. Response: I have revised as per your instruction Comment 9: English needs to be revised. Response: The manuscript has been revised by Editage for English language Submitted filename: Response to Reviewers.docx Click here for additional data file. 14 Jul 2022
PONE-D-21-25497R1
Health hazards related to using masks and/or personal protective equipment among physicians working in public hospitals in Dhaka: a cross-sectional study
PLOS ONE Dear Dr. Mahmud, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.
 
While Reviewer #2 sees all points addressed, Reviewer #3 still has some minor comments.
 
Please submit your revised manuscript by Aug 28 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Christoph Strumann Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #3: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: Reviewer comments Manuscript Number: PONE-D-22-03316R1 Title "Health hazards related to using masks and, or personal protective equipment among the physicians working in different public hospitals in Dhaka: A cross-sectional study". Thank you for providing me the opportunity to review this manuscript that raises important issues about health hazards related to using masks and/or personal protective equipment in one of the developing countries. It seems that all corrections were done. Reviewer #3: The authors of this manuscript have improved upon its quality substantially based on the comments from the first review. However, the authors should address the comments raised below: Line 121: Change these words "As frontliners of this pandemic," to read "As frontliners in the control of this pandemic," Line 124: Are there updated/more recent figures on the mortality of HCWs due to COVID-19? Since this study focused on physicians only, are there specific records for physicians only? Line 154: What are the reasons for selecting these public hospitals? How many public hospitals are in Bangladesh? Are these hospitals representative enough? A map of Bangladesh showing the sampled hospitals would be a good fit. Lines 172-177: As part of the eligibility criteria, the authors should indicate within the manuscript the reason why other HCWs were excluded from the study. Lines 178-181: Authors should include a reference for using the stated formula in calculating the sample size. Furthermore, the authors must include a justification within the manuscript as to the reason why respondents well-above the calculated sample size were recruited into the study. Line 182: I believe the authors have used a non-probability sampling technique "Purposive" since physicians were targeted. It won't be out of place to indicate that a Purposive sampling technique was used. Line 284: Why have the authors considered the use of Relative risk and not odds ratio in this cross-sectional study? Table 1: Authors should include among the keys below the table the full terms of all abbreviations used. Table 3: Authors should include among the keys below the table the full terms of all abbreviations used. The authors should include a paragraph just before the conclusion stating clearly the limitations associated with this study and how these limitations affect the generalizability of their findings. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: Yes: Ismail Ayoade Odetokun (Ph.D.) ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
Submitted filename: Reviewer comments PONE-D-21-25497_R1.docx Click here for additional data file. 23 Aug 2022 In response to review of the manuscript entitled “Health hazards related to using masks and/or personal protective equipment among physicians working in public hospitals in Dhaka: a cross-sectional study”. Dear Sir, Thank you for reviewing my manuscript. I have tried to address each point raised by the academic editor and the reviewers. Response to Academic editor: Thank you for giving me the opportunity to revise the article. Response to the reviewer: Thank you for reviewing the article. I have tried to address all the points raised in your review comments. Reviewer #2: Thank you for providing me the opportunity to review this manuscript that raises important issues about health hazards related to using masks and/or personal protective equipment in one of the developing countries. It seems that all corrections were done. Response: Thank you for accepting the corrections Reviewer #3: The authors of this manuscript have improved upon its quality substantially based on the comments from the first review. However, the authors should address the comments raised below: Line 121: Change these words "As frontliners of this pandemic," to read "As frontliners in the control of this pandemic," Response: Thank you for the correction. I have corrected as per your advice. Line 124: Are there updated/more recent figures on the mortality of HCWs due to COVID-19? Since this study focused on physicians only, are there specific records for physicians only? Response: I have searched extensively for updated/recent figures, but failed to find updated figures on physicians only. I have found an estimate of WHO, So I added the following statement in the manuscript “Reported death to WHO COVID-19 surveillance in health care workers due to COVID -19, from January 2020–May 2021 was only 6643. Still, a population-based estimate revealed that 115 493 health and care workers could have died from COVID-19 during that period” .Line 154: What are the reasons for selecting these public hospitals? How many public hospitals are in Bangladesh? Are these hospitals representative enough? A map of Bangladesh showing the sampled hospitals would be a good fit. Response: There are 3,976 healthcare facilities in the public sector in Bangladesh; It includes union subcenters. Among them, 600 facilities were dedicated to treating COVID-19 patients nationwide. We did the study in Dhaka city, the capital of Bangladesh. In Dhaka city, nine large public hospitals were involved in COVID treatment. Among them, we choose these five hospitals purposively. These hospitals are representative enough of Dhaka city. We did not include other health facilities nationwide, as health facilities outside Dhaka are not homogenous, and there is a communication problem. To avoid redundancy, we did not mention all this information in the manuscript. We corrected the statement below” Among nine large COVID-19 dedicated hospitals in Dhaka city, we purposively selected these five hospitals.” A Map of Dhaka showing this hospital has been attached as supplements. Lines 172-177: As part of the eligibility criteria, the authors should indicate within the manuscript the reason why other HCWs were excluded from the study. Response: added in 195-197. Lines 178-181: Authors should include a reference for using the stated formula in calculating the sample size. Furthermore, the authors must include a justification within the manuscript as to the reason why respondents well-above the calculated sample size were recruited into the study. Response: Reference added line-199, Justification of recruiting repondents well above the calculated sample size added, line-201-203. Line 182: I believe the authors have used a non-probability sampling technique "Purposive" since physicians were targeted. It won't be out of place to indicate that a Purposive sampling technique was used. Response: we deleted the line Line 284: Why have the authors considered the use of Relative risk and not odds ratio in this cross-sectional study? Response: Thanks for pointing this. It was a mistake, so we corrected it. Line 318. Table 1: Authors should include among the keys below the table the full terms of all abbreviations used. Table 3: Authors should include among the keys below the table the full terms of all abbreviations used. Response: Added in the manuscript The authors should include a paragraph just before the conclusion stating clearly the limitations associated with this study and how these limitations affect the generalizability of their findings Response: added in 604-621 lines. Journal Requirements: I have reviewed the references and found one reference might be retracted one, so deleted that reference, number 32. “Warren DW, Mayo R, Zajac DJ, Rochet AH. Dyspnea following experimentally induced increased nasal airway resistance. Cleft Palate Craniofac J. 1996 May;33(3):231-5. doi: 10.1597/1545-1569_1996_033_0231_dfeiin_2.3.co_2. PMID: 8734724.” I have added two more references as per requirement of the reviewers No-8: World Health Organization‎. The impact of COVID-19 on health and care workers: a closer look at deaths. World Health Organization. 2021, Accessed on 10.08.2022. https://apps.who.int/iris/handle/10665/345300. No-16: Daniel WW, editor. 7th ed. New York: John Wiley & Sons; 1999. Biostatistics: a foundation for analysis in the health sciences. I hope I have tried my level best to address all of your point raised during the review process. Please consider my manuscript for publication in PLOS ONE. Thanks Dr. Reaz Mahmud Assistant professor Neurology Dhaka Medical College Submitted filename: Response to Reviewers.docx Click here for additional data file. 24 Aug 2022 Health hazards related to using masks and/or personal protective equipment among physicians working in public hospitals in Dhaka: a cross-sectional study PONE-D-21-25497R2 Dear Dr. Mahmud, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Christoph Strumann Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: 2 Sep 2022 PONE-D-21-25497R2 Health hazards related to using masks and/or personal protective equipment among physicians working in public hospitals in Dhaka: a cross-sectional study Dear Dr. Mahmud: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Christoph Strumann Academic Editor PLOS ONE
  34 in total

1.  Prevalence of SARS-CoV-2 Infection Among Health Care Workers in a Tertiary Community Hospital.

Authors:  Allen Jeremias; James Nguyen; Joseph Levine; Simcha Pollack; William Engellenner; Avni Thakore; Charles Lucore
Journal:  JAMA Intern Med       Date:  2020-12-01       Impact factor: 21.873

2.  Risks of N95 Face Mask Use in Subjects With COPD.

Authors:  Sun Young Kyung; Yujin Kim; Hyunjoong Hwang; Jeong-Woong Park; Sung Hwan Jeong
Journal:  Respir Care       Date:  2020-01-28       Impact factor: 2.258

3.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.

Authors:  J C Bestall; E A Paul; R Garrod; R Garnham; P W Jones; J A Wedzicha
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

Review 4.  Headaches due to external compression.

Authors:  Abouch Valenty Krymchantowski
Journal:  Curr Pain Headache Rep       Date:  2010-08

5.  Objective assessment of increase in breathing resistance of N95 respirators on human subjects.

Authors:  Heow Pueh Lee; De Yun Wang
Journal:  Ann Occup Hyg       Date:  2011-09-05

6.  The changing face of healthcare worker perceptions on powered air-purifying respirators during the SARS outbreak.

Authors:  Kay-Leong Khoo; Poh-Hock Leng; Irwani Bte Ibrahim; T K Lim
Journal:  Respirology       Date:  2005-01       Impact factor: 6.424

7.  Personal Protective Equipment and Headaches: Cross-Sectional Study Among Moroccan Healthcare Workers During COVID-19 Pandemic.

Authors:  Amal Hajjij; Jehanne Aasfara; Mohamed Khalis; Hamid Ouhabi; Fouad Benariba; Chafik El Kettani
Journal:  Cureus       Date:  2020-12-13

8.  COVID-19 infection among healthcare workers: a cross-sectional study in southwest Iran.

Authors:  Golnar Sabetian; Mohsen Moghadami; Leila Hashemizadeh Fard Haghighi; Reza Shahriarirad; Mohammad Javad Fallahi; Naeimehossadat Asmarian; Yalda Sadat Moeini
Journal:  Virol J       Date:  2021-03-17       Impact factor: 4.099

9.  Powered Air Purifying Respirator (PAPR) restores the N95 face mask induced cerebral hemodynamic alterations among Healthcare Workers during COVID-19 Outbreak.

Authors:  Chandra Bharatendu; Jonathan J Y Ong; Yihui Goh; Benjamin Y Q Tan; Amanda C Y Chan; Jonathan Z Y Tang; Aloysius S Leow; Amanda Chin; Kenneth W X Sooi; Yi Lin Tan; Chiew S Hong; Benjamin Z Chin; Elizabeth Ng; Theng Wai Foong; Hock Luen Teoh; Shi Ting Ong; Pyng Lee; Deborah Khoo; Georgios Tsivgoulis; Andrei V Alexandrov; Vijay K Sharma
Journal:  J Neurol Sci       Date:  2020-08-03       Impact factor: 3.181

10.  Commentary: Physiological and Psychological Impact of Face Mask Usage during the COVID-19 Pandemic.

Authors:  Jennifer L Scheid; Shannon P Lupien; Gregory S Ford; Sarah L West
Journal:  Int J Environ Res Public Health       Date:  2020-09-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.